Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Opinion on Biological Therapy|February 16, 2005
Antisense therapy for restenosis following percutaneous coronary interventionNicholas Kipshidze, Mykola Tsapenko, Patrick Iversen, et al.Clinical Transplantation|October 25, 2011
Renal histological lesions and outcome in liver transplant recipientsMykola Tsapenko, Ziad M El-Zoghby, Sanjeev SethiCurrent Pharmaceutical Design|February 18, 2004
Update on sirolimus drug-eluting stentsNicholas Kipshidze, Martin B Leon, Mykola Tsapenko, et al.Journal of the American College of Cardiology|August 18, 2004
Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventionsNicholas Kipshidze, George Dangas, Mykola Tsapenko, et al.BMJ Open|November 22, 2011
Mapping physicians' admission diagnoses to structured concepts towards fully automatic calculation of acute physiology and chronic health evaluation scoreSubhash Chandra, Rahul Kashyap, Cesar A Trillo-Alvarez, et al.Critical Care Medicine|October 21, 2010
Limiting ventilator-induced lung injury through individual electronic medical record surveillanceVitaly Herasevich, Mykola Tsapenko, Marija Kojicic, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 6, 2004
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis modelNicholas N Kipshidze, Patrick Iversen, Han-Soo Kim, et al.Pageof 1